Biotech Industry News
A collection of Biotech latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

Pennsylvania: birthplace of the biotech revolution?
(The Center Square) - The “bioindustrial revolution” is coming. Pennsylvania lawmakers want the commonwealth to be at its forefront. Gov. Josh Shapiro has made the biotech industry a core focus of his work in the governor's office.
Danish biotech Cellugy wants to replace microplastics in cosmetics
Danish biotech Cellugy has raised €8.1mn in EU funding to accelerate production of a biodegradable material designed to replace microplastics in cosmetics. The grant, awarded under the EU's LIFE Programme for environmental projects, will…

Demystifying Krystal Biotech: Insights From 7 Analyst Reviews - Krystal Biotech (NASDAQ:KRYS)
Across the recent three months, 7 analysts have shared their insights on Krystal Biotech, expressing a variety of opinions spanning from bullish to bearish. The following table provides a quick overview of their recent ratings, highlighting the…

Strategies for Choosing the Right Bioanalytical Partner to Accelerate Drug Development, Upcoming Webinar Hosted by Xtalks
Two industry veterans who have spent over 15 years in biotech, pharma and CROs will present their learned experiences about distinguishing partners from vendors during the webinar. The webinar will provide concrete strategies for CRO selection that…

Utopia secures $1.5 mn from Whale Tank to develop obesity vaccine
Biotech player in vaccines for chronic metabolic diseases, Utopia Therapeutics, has secured seed funding of $1.5 million from Whale Tank, a leading early-stage venture firm. The announcement was made at the BIO International Convention 2025. The…

Beyond Bitcoin: Alki David's DNA-Backed Coin Fuses Biotech, Streaming, and Celebrity in the Boldest Crypto Launch Yet
While mainstream crypto headlines this week focused on ETFs and SEC approvals, Alki David quietly detonated a cultural bomb in the blockchain world—with a token you can hold, scan, and clone (almost). The Alki David Coin isn't just a…

It's time to tune out the market noise and focus on your portfolio
Questor is The Telegraph's stock-picking column, helping you decode the markets and offering insights on where to invest. Market noise has been at maximum volume over recent months. Constant updates regarding a highly fluid global trade war, wider…

India trails in critical tech, particularly semiconductor tech
A new global index has been launched to assess how 25 countries perform across five technology sectors: AI, biotechnology, semiconductors, space, and quantum. India lags significantly behind the top three — U.S., China, and Europe —…

The Best Stocks to Invest $1,000 in Right Now | The Motley Fool
Is it time to reload your portfolio with some new picks? That's easier said than done right now. After all, many of yesterday's most popular and promising names have grown to the point where they aren't so promising anymore. It's time to consider a…

This Bacterium Can Turn Your Plastic Bottles Into *Checks Notes* Paracetamol - AKA Tylenol
Paracetamol. Tylenol. Acetaminophen. Whatever you call it, chances are you've had it. As one of the world's most common drugs (though we only just recently figured out how it works), we produce tons of the stuff globally, but it may surprise and…

Ax-4 'Go' For Wednesday Launch; Station Crew Keeps Up Research, Videography
Axiom Mission 4 (Ax-4) has been given the “go” to launch at 2:31 a.m. EDT on Wednesday from NASA's Kennedy Space Center to the International Space Station. The four Ax-4 private astronauts will ride the SpaceX Dragon crew spacecraft…
ALSINOVA, the Astek Group's new CRO aimed at revolutionizing Life Sciences
ALSINOVA, the Astek Group's new CRO aimed at revolutionizing Life Sciences The Astek Group announces the creation of its CRO subsidiary, ALSINOVA, a true strategic partner for Life Sciences manufacturers. This CRO (Contract Research Organization)…

Glaukos Corporation: Delivering Consistent Growth (NYSE:GKOS)
Glaukos Corporation shares have declined 30% since my last review in September, making now an opportune time to reassess the investment case. GKOS Q1 results beat expectations, and the company is delivering on a robust pipeline as it continues to…

Progressing Beyond Exploratory Endpoints: The Value of Digital Biomarkers in Neuroscience Clinical Studies, Upcoming Webinar Hosted by Xtalks
Register for this webinar to explore how integrated digital strategies can enhance data quality and decision-making across psychiatric, neurologic and neurodegenerative clinical trials. Key areas of focus will include: Evaluating the role of…
Vivoryon Therapeutics N.V. Reports Outcome of 2025 Annual General Meeting
Vivoryon Therapeutics N.V. Reports Outcome Halle (Saale) / Munich, Germany, June 24, 2025 - Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; NL00150002Q7) (Vivoryon), a clinical stage company developing small molecule medicines for inflammatory…
Receive a Daily briefing on Biotech Industry News
Get Started